Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Daizaburo Hirata"'
Autor:
Yusuke Nakamura, Satoshi Kondo, Eiju Tsuchiya, Tomoo Ito, Masaki Miyamoto, Tatsuya Kato, Daizaburo Hirata, Takumi Yamabuki, Yataro Daigo, Satoshi Hayama
Through genome-wide gene expression analysis of lung carcinomas, we detected in the great majority of lung cancer samples cotransactivation of cell division cycle associated 8 (CDCA8) and aurora kinase B (AURKB), which were considered to be component
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5fac431dfb31648db8f2d0e80027810f
https://doi.org/10.1158/0008-5472.c.6496419.v1
https://doi.org/10.1158/0008-5472.c.6496419.v1
Autor:
Yusuke Nakamura, Satoshi Kondo, Eiju Tsuchiya, Tomoo Ito, Masaki Miyamoto, Tatsuya Kato, Daizaburo Hirata, Takumi Yamabuki, Yataro Daigo, Satoshi Hayama
Supplementary Figure 3 from Phosphorylation and Activation of Cell Division Cycle Associated 8 by Aurora Kinase B Plays a Significant Role in Human Lung Carcinogenesis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6acd833868bf149624541d2d54e96b28
https://doi.org/10.1158/0008-5472.22370484
https://doi.org/10.1158/0008-5472.22370484
Autor:
Yusuke Nakamura, Satoshi Kondo, Eiju Tsuchiya, Tomoo Ito, Masaki Miyamoto, Tatsuya Kato, Daizaburo Hirata, Takumi Yamabuki, Yataro Daigo, Satoshi Hayama
Supplementary Figure 2A from Phosphorylation and Activation of Cell Division Cycle Associated 8 by Aurora Kinase B Plays a Significant Role in Human Lung Carcinogenesis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a231dc38bf786e1fc0123912703faf9
https://doi.org/10.1158/0008-5472.22370487
https://doi.org/10.1158/0008-5472.22370487
Autor:
Yusuke Nakamura, Satoshi Kondo, Eiju Tsuchiya, Tomoo Ito, Masaki Miyamoto, Tatsuya Kato, Daizaburo Hirata, Takumi Yamabuki, Yataro Daigo, Satoshi Hayama
Supplementary Figure 1B from Phosphorylation and Activation of Cell Division Cycle Associated 8 by Aurora Kinase B Plays a Significant Role in Human Lung Carcinogenesis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52f856aa12c5b28d4d558939b6323021
https://doi.org/10.1158/0008-5472.22370490.v1
https://doi.org/10.1158/0008-5472.22370490.v1
Autor:
Yusuke Nakamura, Masahiro Fujita, Yataro Daigo, Takumi Yamabuki, Daiki Miki, Kazuaki Chayama, Tomoo Ito, Masao Hosokawa, Eiju Tsuchiya, Daizaburo Hirata
Publikováno v:
Clinical Cancer Research. 15:256-266
Purpose: This study aims to isolate potential molecular targets for diagnosis, treatment, and/or prevention of lung and esophageal carcinomas. Experimental Design: We screened for genes that were frequently overexpressed in the tumors through gene ex
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e022109009e0e76dbd0b6efede84fb2
https://doi.org/10.1158/1078-0432.ccr-08-1672
https://doi.org/10.1158/1078-0432.ccr-08-1672
Autor:
Yusuke Nakamura, Tatsuya Kato, Satoshi Hayama, Tomoo Ito, Satoshi Kondo, Eiju Tsuchiya, Masaki Miyamoto, Yataro Daigo, Takumi Yamabuki, Daizaburo Hirata
Publikováno v:
Cancer Research. 67:4113-4122
Through genome-wide gene expression analysis of lung carcinomas, we detected in the great majority of lung cancer samples cotransactivation of cell division cycle associated 8 (CDCA8) and aurora kinase B (AURKB), which were considered to be component
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b90c1b0ef2363df469e9261e4badf301
https://doi.org/10.1158/0008-5472.can-06-4705
https://doi.org/10.1158/0008-5472.can-06-4705
Autor:
Hiromi Abe, C. Nelson Hayes, Ichimaro Yamada, Eiji Iwao, Tomohiko Kono, Naohiro Kamiya, Kazuaki Chayama, Hidenori Ochi, Tomokazu Kawaoka, Masataka Tsuge, Daizaburo Hirata, Nobuhiko Hiraga, Chise Tateno, Shoichi Takahashi, Fukiko Mitsui, Eiji Ohara, Mayu Onishi, Katsutoshi Yoshizato, Shinji Tanaka, Michio Imamura
Publikováno v:
Journal of hepatology. 54(5)
Background & Aims The current treatment regimen for chronic hepatitis C virus (HCV) infection is peg-interferon plus ribavirin combination therapy. The majority of developing therapeutic strategies also contain peg-interferon with or without ribaviri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::936f328e2a4bc07a337f8671f7ff94c7
https://pubmed.ncbi.nlm.nih.gov/21145816
https://pubmed.ncbi.nlm.nih.gov/21145816
Autor:
Daizaburo, Hirata, Hideharu, Okanobu, Yoshio, Kuga, Hiroki, Imagawa, Yoshito, Takemura, Tomotaka, Tanaka, Takashi, Moriya, Toshihide, Ohya, Akira, Maruhashi, Makoto, Takahashi, Tosihiro, Nishida
Publikováno v:
Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology. 102(12)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1021b2019807edb2537fdc1cd3f3d0da
https://pubmed.ncbi.nlm.nih.gov/16372769
https://pubmed.ncbi.nlm.nih.gov/16372769